Trials / Completed
CompletedNCT03945344
Effect of Charcoal on Gastrointestinal Absorption of Tiotropium
Effect of Charcoal on Gastrointestinal Absorption of Tiotropium; A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The study will assess how efficiently activated charcoal will block absorption of tiotropium via the gastro intestinal track. Pharmacokinetics of tiotropium will be compared after orally administered tiotropium capsule with and without concomitant activated charcoal administration in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tiotropium | Oral capsule 20 μg |
| DRUG | Tiotropium | Oral capsule 20 μg |
Timeline
- Start date
- 2019-05-27
- Primary completion
- 2019-06-19
- Completion
- 2019-06-19
- First posted
- 2019-05-10
- Last updated
- 2019-09-23
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT03945344. Inclusion in this directory is not an endorsement.